Formulation stability & analysis in support of a single triple-therapy auto-injector

There is a requirement to deliver one therapy containing 3 active drugs. Due to the indication of the therapy, it is necessary for an end user to self-administer the drugs via an auto injector. The follow-on therapy requires the drug to be administered as an i.v. infusion. Due to the nature of the drugs, the authority requires formulation stability & analysis in support of a single triple-therapy autoinjector Additional information: https://in-tendhost.co.uk/dstl/aspx/Home Is a Recurrent Procurement Type? : No